Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.
For overlap across multiple ETFs use Portfolio Builder
45
Number of overlapping holdings
12.6%
% of FHLC's 372 holdings also in HELX
78.9%
% of HELX's 68 holdings also in FHLC
Overlap by Weight
Sector Drift (FHLC minus HELX)
Overlapping Holdings
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
| Company | Weight in FHLC |
Weight in HELX |
Overlap | |
|---|---|---|---|---|
 |
ELI LILLY & CO | 10.2% | 4.2% | 4.2% |
|
THERMO FISHER SCIENTIFIC INC | 3.6% | 6.2% | 3.6% |
|
DANAHER CORP | 2.9% | 5.4% | 2.9% |
|
VERTEX PHARMACEUTICALS INC | 1.8% | 4.8% | 1.8% |
|
REGENERON PHARMACEUTICALS | 1.7% | 4.6% | 1.7% |
Position Highlights (Non-Overlapping Exposures)
FHLC Overweight Relative to HELX
|
UNITEDHEALTH GROUP INC | 7.3% |
|
JOHNSON & JOHNSON | 6.3% |
|
ELI LILLY & CO | 6.0% |
|
MERCK & CO. INC. | 5.2% |
|
ABBVIE INC | 5.1% |
|
ABBOTT LABORATORIES | 3.3% |
|
PFIZER INC | 2.4% |
|
AMGEN INC | 2.4% |
|
INTUITIVE SURGICAL INC | 2.3% |
|
STRYKER CORP | 2.0% |
FHLC Underweight Relative to HELX
|
MEDPACE HOLDINGS, INC. | -7.8% |
|
KRYSTAL BIOTECH, INC. | -3.7% |
 |
SARTORIUS AG PREF | -3.1% |
|
BRUKER CORP | -3.1% |
|
VERTEX PHARMACEUTICALS INC | -3.0% |
|
REGENERON PHARMACEUTICALS | -2.9% |
 |
SAMSUNG BIOLOGICS CO., LTD. | -2.9% |
|
IONIS PHARMACEUTICALS, INC. | -2.6% |
|
THERMO FISHER SCIENTIFIC INC | -2.6% |
|
DANAHER CORP | -2.5% |